This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_PENIS_EXALLC for full statistics.
Carcinoma in situ of penis
CD2_INSITU_PENIS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditions
|
226721 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
54 |
4. Check minimum number of eventsNone |
54 |
5. Include endpointsNone |
54 |
6. Filter based on genotype QC (FinnGen only) |
54 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D07
- Name in latin
- Carcinoma in situ vesicae urinariae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of penis
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of penis
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 54 | - | 54 |
| Unadjusted period prevalence (%) | 0.02 | - | 0.02 |
| Median age at first event (years) | 66.19 | - | 66.19 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
15
18
11.15
12.11
1.6
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
20
72
3.82
4.95
1.8
2.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
23
5.11
4.29
2.3
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
31
165
3.06
3.93
3.6
2.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
29
151
2.99
3.79
13.2
6.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
15
55
3.39
3.50
1.3
2.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
11
7.12
3.30
1.6
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
21
99
2.83
3.19
14.1
7.0
—
—
—
0
0
(4035726)
13
46
3.41
3.18
1.7
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
15
60
3.08
3.02
1.5
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
17
77
2.76
2.73
4.0
2.6
e6/l
0.8
0.5
0.17
12
43
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
17
78
2.72
2.66
3.9
2.3
e6/l
0.2
0.6
1.59
11
44
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
36
3.18
2.35
2.0
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
33
219
2.30
2.25
9.6
6.1
e9/l
0.7
0.6
0.29
27
192
(3006315) Basophils [#/volume] in Blood
33
219
2.30
2.25
9.6
6.2
e9/l
0.0
0.0
0.08
27
193
(3013115) Eosinophils [#/volume] in Blood
33
223
2.23
2.11
10.8
6.5
e9/l
0.2
0.2
0.04
28
199
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
16
80
2.42
2.06
3.0
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
127
2.24
2.05
4.5
2.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
21
3.67
2.04
1.7
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
21
3.67
2.04
3.0
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
179
2.17
2.03
2.4
1.8
pmol/l
95.5
86.4
0.34
16
108
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
22
3.50
1.95
2.4
2.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
16
83
2.32
1.89
3.1
3.5
ng/l
31.9
173.0
1.55
11
67
(3000492) Spirometry study
10
41
2.77
1.88
2.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
29
196
2.04
1.75
12.9
13.9
e9/l
0.0
0.0
0.51
23
165
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
14
3.82
1.65
1.2
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
28
191
1.97
1.61
4.9
5.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
22
139
1.98
1.56
3.8
3.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
60
2.29
1.52
1.4
1.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
15
84
2.09
1.45
3.4
2.0
umol/l
14.7
12.6
0.37
15
75
(3009542) Hematocrit [Volume Fraction] of Blood
43
348
2.16
1.44
37.5
18.8
%
40.5
41.1
0.25
33
231
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
26
178
1.89
1.44
5.0
3.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
199
1.85
1.36
3.8
4.3
ng/l
34.3
36.4
0.07
21
154
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
13
71
2.09
1.33
3.7
1.9
%
28.7
23.4
0.41
13
62
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
56
2.21
1.33
2.1
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
14
79
2.04
1.32
3.3
1.9
g/l
2.2
2.2
0.01
14
69
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
18
2.95
1.31
1.0
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
18
2.95
1.31
8.6
41.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
18
2.95
1.31
3.6
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
24
164
1.83
1.31
7.5
5.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
149
0.46
1.29
3.1
3.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
17
105
1.90
1.25
4.2
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
39
2.23
1.21
9.1
9.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
51
2.18
1.20
2.2
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
20
2.65
1.18
1.2
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
20
2.65
1.18
4.8
2.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
7
31
2.44
1.15
2.1
2.4
ng/l
106.1
223.3
—
7
26
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
29
218
1.71
1.10
3.3
2.3
—
—
—
0
0
(4034850)
0
28
0.00
1.01
0.0
14.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
41
347
1.75
0.93
15.1
8.8
u/l
89.4
79.6
0.58
36
331
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
45
395
1.83
0.85
27.9
17.1
ml/min/173m2
78.5
78.3
0.02
37
332
(3007853) Bacteria identified in Skin by Aerobe culture
8
47
1.82
0.85
1.5
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
27
0.00
0.80
0.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
47
423
1.86
0.79
33.4
18.5
mg/l
40.0
27.0
0.79
40
357
(40768797) Stomach Pathology biopsy report
9
56
1.73
0.77
1.3
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
39
1.91
0.76
2.0
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
26
2.01
0.72
9.6
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
34
284
1.53
0.72
6.6
4.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
42
1.76
0.71
3.7
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
14
97
1.60
0.67
2.7
2.8
e6/l
4.6
3.0
0.37
14
83
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
97
1.60
0.67
4.6
2.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
11
72
1.66
0.65
1.7
1.3
g/l
2.1
2.5
—
5
44
(3003694) ABO and Rh group [Type] in Blood
15
107
1.56
0.64
1.2
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
8
53
1.60
0.62
6.8
19.6
mmol/l
-0.3
1.2
—
8
39
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
39
342
1.51
0.60
5.7
5.1
ug/l
3.7
3.6
0.01
33
310
(3009343) pH of Capillary blood
6
36
1.75
0.59
9.2
4.1
—
7.4
—
0
5
(4010399)
6
37
1.70
0.58
1.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
9
64
1.49
0.55
1.3
1.2
—
0.8
—
0
16
(40761535) Cells panel - Urine sediment
6
39
1.60
0.55
8.2
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
7
47
1.56
0.50
1.9
1.8
%
1.5
2.2
—
7
36
(3022145) Colonoscopy Study observation
7
48
1.53
0.49
1.7
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
35
307
1.40
0.49
4.6
4.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
101
0.65
0.45
5.4
4.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
32
1.62
0.43
3.0
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
32
1.62
0.43
6.8
7.2
mmol/l
23.4
24.8
—
5
32
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
5
32
1.62
0.43
2.6
2.5
—
58.3
—
0
13
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
15
0.00
0.42
0.0
1.5
—
0.0
—
0
7
(3012501) Base excess in Blood by calculation
0
16
0.00
0.42
0.0
2.8
—
2.9
—
0
10
(3027315) Oxygen [Partial pressure] in Blood
0
16
0.00
0.42
0.0
2.8
—
7.9
—
0
16
(3013290) Carbon dioxide [Partial pressure] in Blood
0
16
0.00
0.42
0.0
2.8
—
5.1
—
0
16
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
42
1.48
0.37
1.8
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
169
0.77
0.29
4.2
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
5
38
1.35
0.24
10.0
3.3
mmol/l
0.6
2.3
—
5
28
(4094501)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
1.0
—
0
10
(3042631) Mycobacterium sp identified in Specimen
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
5.9
—
1.6
—
0
12
(3038515) Glucose [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
5.9
—
7.0
—
0
12
(40767503) Oxygen content in Capillary blood by calculation
0
13
0.00
0.21
0.0
3.2
—
15.0
—
0
7
(3006184) Hemoglobin [Mass/volume] in Capillary blood
0
13
0.00
0.21
0.0
3.0
—
122.3
—
0
8
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
2.3
—
228.6
—
0
8
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
59
1.21
0.19
4.1
4.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
10
119
0.80
0.17
2.6
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
13
112
1.21
0.16
3.6
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
45
432
1.25
0.14
25.8
18.3
—
—
—
0
0
(3019225) pH of Specimen
5
46
1.10
0.10
8.4
5.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
55
1.10
0.09
11.3
9.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
28
272
1.06
0.02
4.2
4.5
%
16.6
21.7
1.00
13
140
(3032080) INR in Blood by Coagulation assay
22
214
1.05
0.00
9.2
10.7
inr
1.5
1.3
—
6
74
(3013512) EKG study
15
146
1.04
0.00
7.1
5.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
8
0.00
0.00
0.0
1.6
—
4.9
—
0
8
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
11.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.7
—
4.0
—
0
9
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
5.0
—
6.5
—
0
6
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5
58
0.85
0.00
2.4
5.3
ug/l
3.1
81.6
—
5
49
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
15.6
—
0
5
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
0.3
—
0
9
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
2.0
—
1.6
—
0
9
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
16.8
—
1065.8
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
12.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.7
—
105.2
—
0
9
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.6
—
584.8
—
0
5
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
0.00
0.0
2.2
—
59.3
—
0
9
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_PENIS – Carcinoma in situ of penis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).